Healthcare [ 7/13 ] | Biotechnology [ 82/163 ]
NASDAQ | Common Stock
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder.
It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders.
The company was founded in 2010 and is based in Glen Allen, Virginia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 13, 24 | -1.35 Decreased by -1.13 K% | -0.33 Decreased by -309.09% |
| Feb 20, 24 | -1.35 Decreased by -1.19 K% | -0.76 Decreased by -77.63% |
| Nov 14, 23 | -1.18 Decreased by -883.33% | -1.13 Decreased by -4.42% |
| Aug 21, 23 | 0.96 Increased by +700.00% | -1.50 Increased by +164.00% |
| May 12, 23 | -0.11 Increased by +15.38% | -0.14 Increased by +21.43% |
| Mar 30, 23 | -0.10 Increased by +62.50% | -0.15 Increased by +30.00% |
| Nov 14, 22 | -0.12 Increased by +45.45% | -0.18 Increased by +33.33% |
| Aug 15, 22 | -0.16 Increased by +36.00% | -0.14 Decreased by -14.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | N/A Decreased by N/A% | -1.92 M Increased by +33.01% | - - |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.38 M Increased by +54.31% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | 1.09 M Increased by +128.15% | Increased by +N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -2.89 M Decreased by -4.87% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -2.87 M Increased by +50.84% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -3.03 M Increased by +29.80% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -3.86 M Increased by +12.98% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -2.76 M Increased by +42.97% | Decreased by N/A% Decreased by N/A% |